Detection of Previously Unidentified Metastatic Disease as a Leading Cause of Screening Failure in a Phase III Trial of Zibotentan Versus Placebo in Patients with Nonmetastatic, Ca...

Por Yu, Evan Y., Miller, Kurt, Nelson, Joel, Gleave, Martin, Fizazi, Karim, Moul, Judd W., Nathan, Faith E., Higano, Celestia S.
Publicado em 2012